Sangamo BioSciences, Inc. misses by $0.03, beats on revenue

|About: Sangamo Therapeutics, Inc. (SGMO)|By:, SA News Editor

Sangamo BioSciences, Inc. (SGMO): Q4 EPS of -$0.13 misses by $0.03.

Revenue of $6.9M (-22.7% Y/Y) beats by $1.21M.